Search results
Results from the Health.Zone Content Network
McKesson Corporation is a publicly-traded American company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceuticals used in North America and employs over 51,000 employees. With $263.9 billion in 2023 revenue, it is the ninth ...
The McKesson and Robbins scandal, which occurred in 1938, was one of the major financial scandals of the 20th century. The company, McKesson and Robbins, Inc., which is now McKesson Corporation , was taken over in 1925 by Phillip Musica , who had previously used Adelphia Pharmaceutical Manufacturing Company as a front for bootlegging operations.
McKesson expects 2024 adjusted profit of $26.55 to $27.35 per share, from a prior forecast of $26.10 to $26.90 per share. Analysts estimate a profit of $26.63. Excluding items, the company ...
Saint Paul, Minnesota, Minnesota. Occupation (s) CEO of McKesson Corporation, Retired. John H. Hammergren is an American businessman. He is best known for his role as chairman and CEO of McKesson Corporation since 1999. [1] On November 1, 2018, Hammergren announced his plan to retire. [2] On April 1, 2019, he officially retired from McKesson.
The mid-point of the company's 2020 adjusted profit outlook of between $13.85 and $14.45 per share was a cent above the average analyst estimate, according to IBES data from Refinitiv.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
McKesson Reports Fiscal 2013 Third-Quarter Results Revenues of $31.2 billion for the third quarter, up 1%. Third-quarter GAAP earnings per diluted share of $1.24, up 3%. Third-quarter Adjusted ...
McKesson's (MCK) fiscal second-quarter results are likely to reflect the solid show by the U.S. Pharmaceutical and Specialty Solutions segment.